BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26658995)

  • 1. microRNA in Malignant Lymphoma.
    Tagawa H
    Adv Exp Med Biol; 2015; 889():41-50. PubMed ID: 26658995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.
    Ikeda S; Tagawa H
    Int J Hematol; 2014; 99(5):542-52. PubMed ID: 24567260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs in the Malignant Transformation Process.
    Sarver AE; Li L; Kartha RV; Subramanian S
    Adv Exp Med Biol; 2015; 889():1-21. PubMed ID: 26658993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia.
    Maimaiti A; Abudoukeremu K; Tie L; Pan Y; Li X
    Gene; 2015 Mar; 558(2):271-7. PubMed ID: 25576219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of microRNA alterations in leukemias and lymphomas.
    Calin GA; Croce CM
    Methods Enzymol; 2007; 427():193-213. PubMed ID: 17720486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNA in the pathogenesis of malignant lymphoma.
    Tagawa H; Ikeda S; Sawada K
    Cancer Sci; 2013 Jul; 104(7):801-9. PubMed ID: 23551855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.
    Ishimoto T; Baba H; Izumi D; Sugihara H; Kurashige J; Iwatsuki M; Tan P
    Int J Cancer; 2016 Mar; 138(6):1337-49. PubMed ID: 26041092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs: Key Players in Hematopoiesis.
    Raghuwanshi S; Karnati HK; Sarvothaman S; Gutti U; Saladi RG; Tummala PR; Gutti RK
    Adv Exp Med Biol; 2015; 887():171-211. PubMed ID: 26662992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory roles and therapeutic potential of microRNA in sarcoma.
    Lim HJ; Yang JL
    Crit Rev Oncol Hematol; 2016 Jan; 97():118-30. PubMed ID: 26318097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MicroRNA in Various Aspects of Cancer Development].
    Nambara S; Mimori K
    Gan To Kagaku Ryoho; 2017 May; 44(5):362-366. PubMed ID: 28536328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.
    Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S
    Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
    Wang LQ; Liang R; Chim CS
    Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs and Soft Tissue Sarcomas.
    Fujiwara T; Kunisada T; Takeda K; Ozaki T
    Adv Exp Med Biol; 2015; 889():179-99. PubMed ID: 26659002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs and lymphomagenesis: a functional review.
    Lawrie CH
    Br J Haematol; 2013 Mar; 160(5):571-81. PubMed ID: 23205669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
    Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
    Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
    Solé C; Larrea E; Di Pinto G; Tellaetxe M; Lawrie CH
    Cancer Lett; 2017 Oct; 405():79-89. PubMed ID: 28757417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.